Enteric-coated aspirin 325 mg
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Enteric-coated aspirin 325 mg, covering 2016-01-21 to 2016-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers [Phase 3]